Radiation Therapy News and Research

RSS

Radiation therapy (also called radiotherapy, x-ray therapy, or irradiation) is the use of a certain type of energy (called ionizing radiation) to kill cancer cells and shrink tumors. Radiation therapy injures or destroys cells in the area being treated (the “target tissue”) by damaging their genetic material, making it impossible for these cells to continue to grow and divide. Although radiation damages both cancer cells and normal cells, most normal cells can recover from the effects of radiation and function properly. The goal of radiation therapy is to damage as many cancer cells as possible, while limiting harm to nearby healthy tissue.

Saint Mary's and Sierra Neurosurgery Group partner to create Nevada's first Brain Tumor Center

Saint Mary's and Sierra Neurosurgery Group have partnered to create the region's first Brain Tumor Center in an effort to speed up the time between diagnosis and treatment.

8 Apr 2010

Martina undergoing therapy for breast cancer, urges women to be more vigilant

The tennis legend Martina Navratilova has revealed on Wednesday that she is undergoing therapy for breast cancer. She has always been revered for her health and performance. Just a month short of her 50th birthday, Navratilova won her last grand slam title, the mixed doubles at the 2006 US Open, and in retirement she wrote a 'how-to' book about good living. She was a winner of a record nine Wimbledon singles titles, 59 grand slam titles, including 18 singles trophies and arguably the greatest female athlete of all time.

8 Apr 2010

First proton therapy center for New Jersey

Cancer survivors joined representatives from ProCure Treatment Centers, Inc., Princeton Radiation Oncology, and CentraState Healthcare System to break ground on the ProCure Proton Therapy Center in Somerset - the first proton therapy center to be built in the state, located 40 miles from downtown Manhattan.

8 Apr 2010

Dutasteride may help reduce risk of developing prostate cancer, say researchers

A drug already used to shrink benign, enlarged prostates could also help to reduce the risk of developing prostate cancer, according to researchers in the US.

8 Apr 2010

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Patients suffering from recently diagnosed malignant brain tumors called glioblastoma multiforme or a rare variant called gliosarcoma may be eligible to participate in a Phase II clinical trial at Cedars-Sinai Medical Center that combines two innovative drugs.

8 Apr 2010

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

Oraya Therapeutics, Inc. announces today that a leading European notified body has granted approval to designate the CE mark to Oraya's IRayTM stereotactic radiotherapy system. Under development since 2007, the IRay is designed specifically to treat diseases of the eye, and the technology enables precise delivery of low energy X-rays for the treatment of wet age-related macular degeneration (AMD).

8 Apr 2010

IZI Medical Products introduces Mammography Indicator Markers

IZI Medical Products today announced that the company has developed and begun distributing two new lines of flat mammography markers, which are being manufactured in the United States and sold worldwide under the brand, Mammography Indicator® Markers.

7 Apr 2010

African-American women with advanced breast cancer have poorer survival rates

African-American women have poorer survival rates than their white and Hispanic counterparts regardless of whether they receive radiation therapy following lumpectomy or mastectomy, UC Davis researchers have found.

7 Apr 2010

Newer treatments, closer monitoring of childhood cancer may improve longevity

Although more children today are surviving cancer than ever before, young patients successfully treated in the 1970s and 80s may live a decade less, on average, than the general population, according to a study from Dana-Farber Cancer Institute and the Harvard School of Public Health.

7 Apr 2010

Par Pharmaceutical, sanofi-aventis resolve patent litigation case

Par Pharmaceutical Companies, Inc. today announced that it (and its subsidiary Par Pharmaceutical and development partner MN Pharmaceuticals of Turkey) has entered into a settlement agreement with sanofi-aventis that resolves patent litigation related to its generic version of sanofi's and Debiopharm's Eloxatin® (oxaliplatin injection) product, a drug used to treat colorectal cancer, in the U.S. District Court for the District of New Jersey.

6 Apr 2010

Identification and elimination of cancer stem cells

A new field of cancer research could explain why some cancers that appear to have been cured can rear their ugly head or spread to other organs.

3 Apr 2010

Cancer research at Georgia Tech: Report

Cancer treatment typically involves surgery, radiation therapy, chemotherapy, hormone therapy or biological therapy. An oncologist may use one therapy or a combination of methods, depending on the type and location of the cancer, whether the disease has spread, the patient's age and general health, and other factors.

3 Apr 2010

SBRT effective in primary tumor control, study finds

Many of the world's leading radiation oncologists are employing the unique capabilities of SBRT to treat a variety of cancers that often have defied conventional radiation therapy techniques. A multitude of studies evaluating SBRT are ongoing and investigators are publishing articles that demonstrate the effectiveness of this technique. Two studies led by renowned radiation oncologists were conducted at centers that use Elekta SBRT technology, and their results were published recently.

From Elekta 2 Apr 2010

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

A drug already prescribed to shrink benign, enlarged prostates has been shown to reduce the risk of a prostate cancer diagnosis by 23 percent in men with an increased risk of the disease, a large international trial has found. Results are reported April 1 in the New England Journal of Medicine.

2 Apr 2010

Implementation of wait time guarantees: Unfulfilled promises

The Wait Time Alliance (WTA) today expressed disappointment that some jurisdictions have still not fulfilled their 2007 promise to implement wait time guarantees, and other jurisdictions have implemented guarantees that are inconsistent and weak.

1 Apr 2010

MITA supports FDA's interest to reduce exposure to medical radiation, minimize medical errors

The Medical Imaging & Technology Alliance, the leading association representing the manufacturers, innovators and developers of medical imaging and radiation therapy systems, today said it is supportive of the Food and Drug Administration's ongoing interest to further reduce exposure to unnecessary medical radiation and minimize medical errors.

31 Mar 2010

Breast cancer patients undertreated, essential radiation after mastectomy not performed

While radiation therapy is common after breast conserving surgery, it's much less frequent after mastectomy, even among women for whom it would have clear life-saving benefit. This is according to a new study from researchers at the University of Michigan Comprehensive Cancer Center.

30 Mar 2010

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Former England Rugby World Cup winner Matt Dawson today launched the 'Because Life is for Living' campaign to raise awareness about brachytherapy, a very precise and highly effective form of radiotherapy to treat cancer.

30 Mar 2010

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Nearly 45 thousand women are diagnosed with breast cancer each year. Two third of these women need a combination of surgery and radiotherapy. Radiotherapy can kill cancer cells that may have been missed during operation. These remnant cells are responsible for 90% relapses.

29 Mar 2010

Sutter Solano Cancer Center earns three-year accreditation from ACOS

Sutter Solano Cancer Center has earned a three-year accreditation with six commendations from the Commission on Cancer of the American College of Surgeons. ACOS approval is awarded to centers that have voluntarily committed to providing the highest level of quality cancer care and undergo regular evaluations and reviews of their performance.

27 Mar 2010

Radiation Therapy News and Research

Further Reading

Saint Mary's and Sierra Neurosurgery Group partner to create Nevada's first Brain Tumor Center

Martina undergoing therapy for breast cancer, urges women to be more vigilant

First proton therapy center for New Jersey

Dutasteride may help reduce risk of developing prostate cancer, say researchers

Phase II clinical trial of Avastin and Tarceva in patients with glioblastoma multiforme

Oraya Therapeutics' IRay stereotactic radiotherapy system granted European CE Mark approval

IZI Medical Products introduces Mammography Indicator Markers

African-American women with advanced breast cancer have poorer survival rates

Newer treatments, closer monitoring of childhood cancer may improve longevity

Par Pharmaceutical, sanofi-aventis resolve patent litigation case

Identification and elimination of cancer stem cells

Cancer research at Georgia Tech: Report

SBRT effective in primary tumor control, study finds

International, four-year study finds dutasteride reduces risk of prostate cancer diagnosis in men

Implementation of wait time guarantees: Unfulfilled promises

MITA supports FDA's interest to reduce exposure to medical radiation, minimize medical errors

Breast cancer patients undertreated, essential radiation after mastectomy not performed

'Because Life is for Living' campaign launched to raise awareness about brachytherapy

Six weeks of radiotherapy to be consolidated into 30 minutes for breast cancer patients

Sutter Solano Cancer Center earns three-year accreditation from ACOS

Evaluating new approaches for rare disease genomics

Expanding access to NMR with the Fourier 80 Duo

Advancing Intracellular Delivery with LumiPore®

Latest News